In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment
Chronic HCV infection is characterized by several immunological alterations, such as the accumulation of suppressor cells and of hyperactivated T lymphocytes. However, it is unclear whether direct-acting antiviral (DAA)-mediated HCV clearance restores immune dysfunctions. We performed a phenotypic c...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2019.00190/full |
id |
doaj-720cc52a9c5c43198976066e414ff35b |
---|---|
record_format |
Article |
spelling |
doaj-720cc52a9c5c43198976066e414ff35b2020-11-25T01:48:29ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882019-06-01910.3389/fcimb.2019.00190455712In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral TreatmentValentina Telatin0Francesco Nicoli1Chiara Frasson2Nicola Menegotto3Francesco Barbaro4Eleonora Castelli5Elke Erne6Giorgio Palù7Antonella Caputo8Department of Molecular Medicine, University of Padova, Padova, ItalyDepartment of Molecular Medicine, University of Padova, Padova, ItalyIstituto di Ricerca Pediatrica (IRP) Città della Speranza, Padova, ItalyDepartment of Molecular Medicine, University of Padova, Padova, ItalyInfectious and Tropical Diseases Unit, Azienda Ospedaliera di Padova, Padova, ItalyInfectious and Tropical Diseases Unit, Azienda Ospedaliera di Padova, Padova, ItalyInfectious and Tropical Diseases Unit, Azienda Ospedaliera di Padova, Padova, ItalyDepartment of Molecular Medicine, University of Padova, Padova, ItalyDepartment of Molecular Medicine, University of Padova, Padova, ItalyChronic HCV infection is characterized by several immunological alterations, such as the accumulation of suppressor cells and of hyperactivated T lymphocytes. However, it is unclear whether direct-acting antiviral (DAA)-mediated HCV clearance restores immune dysfunctions. We performed a phenotypic characterization by flow cytometry of different immune cell subsets, including monocytic myeloid-derived suppressor cells (M-MDSCs) and T lymphocytes in 168 patients with persistent HCV infection not treated, under DAA therapies and sustained virological responders. Chronic HCV infection prompted the accumulation of M-MDSCs independently of patient and clinical characteristics, and altered their metabolic properties. HCV RNA was undetectable in the majority of patients just after few weeks of DAA therapy, whereas M-MDSC levels normalized only 6 months after therapy. In addition, HCV infection deeply perturbed the T cell compartment since a re-distribution of memory CD4+ and CD8+ T cells was observed at the expenses of naïve cells, and memory T lymphocytes displayed increased activation. Notably, these features were only partially restored by DAA therapies in the CD4, but not in the CD8, compartment as high immune activation levels persisted in the terminally differentiated memory CD8+ T cells even more than 1 year after sustained virological response. Together, these results suggest that successful DAA therapies do not lead to full immunological reconstitution as fast as viral clearance.https://www.frontiersin.org/article/10.3389/fcimb.2019.00190/fullHCVDAAM-MDCSsTregsT lymphocytes |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Valentina Telatin Francesco Nicoli Chiara Frasson Nicola Menegotto Francesco Barbaro Eleonora Castelli Elke Erne Giorgio Palù Antonella Caputo |
spellingShingle |
Valentina Telatin Francesco Nicoli Chiara Frasson Nicola Menegotto Francesco Barbaro Eleonora Castelli Elke Erne Giorgio Palù Antonella Caputo In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment Frontiers in Cellular and Infection Microbiology HCV DAA M-MDCSs Tregs T lymphocytes |
author_facet |
Valentina Telatin Francesco Nicoli Chiara Frasson Nicola Menegotto Francesco Barbaro Eleonora Castelli Elke Erne Giorgio Palù Antonella Caputo |
author_sort |
Valentina Telatin |
title |
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment |
title_short |
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment |
title_full |
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment |
title_fullStr |
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment |
title_full_unstemmed |
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment |
title_sort |
in chronic hepatitis c infection, myeloid-derived suppressor cell accumulation and t cell dysfunctions revert partially and late after successful direct-acting antiviral treatment |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cellular and Infection Microbiology |
issn |
2235-2988 |
publishDate |
2019-06-01 |
description |
Chronic HCV infection is characterized by several immunological alterations, such as the accumulation of suppressor cells and of hyperactivated T lymphocytes. However, it is unclear whether direct-acting antiviral (DAA)-mediated HCV clearance restores immune dysfunctions. We performed a phenotypic characterization by flow cytometry of different immune cell subsets, including monocytic myeloid-derived suppressor cells (M-MDSCs) and T lymphocytes in 168 patients with persistent HCV infection not treated, under DAA therapies and sustained virological responders. Chronic HCV infection prompted the accumulation of M-MDSCs independently of patient and clinical characteristics, and altered their metabolic properties. HCV RNA was undetectable in the majority of patients just after few weeks of DAA therapy, whereas M-MDSC levels normalized only 6 months after therapy. In addition, HCV infection deeply perturbed the T cell compartment since a re-distribution of memory CD4+ and CD8+ T cells was observed at the expenses of naïve cells, and memory T lymphocytes displayed increased activation. Notably, these features were only partially restored by DAA therapies in the CD4, but not in the CD8, compartment as high immune activation levels persisted in the terminally differentiated memory CD8+ T cells even more than 1 year after sustained virological response. Together, these results suggest that successful DAA therapies do not lead to full immunological reconstitution as fast as viral clearance. |
topic |
HCV DAA M-MDCSs Tregs T lymphocytes |
url |
https://www.frontiersin.org/article/10.3389/fcimb.2019.00190/full |
work_keys_str_mv |
AT valentinatelatin inchronichepatitiscinfectionmyeloidderivedsuppressorcellaccumulationandtcelldysfunctionsrevertpartiallyandlateaftersuccessfuldirectactingantiviraltreatment AT francesconicoli inchronichepatitiscinfectionmyeloidderivedsuppressorcellaccumulationandtcelldysfunctionsrevertpartiallyandlateaftersuccessfuldirectactingantiviraltreatment AT chiarafrasson inchronichepatitiscinfectionmyeloidderivedsuppressorcellaccumulationandtcelldysfunctionsrevertpartiallyandlateaftersuccessfuldirectactingantiviraltreatment AT nicolamenegotto inchronichepatitiscinfectionmyeloidderivedsuppressorcellaccumulationandtcelldysfunctionsrevertpartiallyandlateaftersuccessfuldirectactingantiviraltreatment AT francescobarbaro inchronichepatitiscinfectionmyeloidderivedsuppressorcellaccumulationandtcelldysfunctionsrevertpartiallyandlateaftersuccessfuldirectactingantiviraltreatment AT eleonoracastelli inchronichepatitiscinfectionmyeloidderivedsuppressorcellaccumulationandtcelldysfunctionsrevertpartiallyandlateaftersuccessfuldirectactingantiviraltreatment AT elkeerne inchronichepatitiscinfectionmyeloidderivedsuppressorcellaccumulationandtcelldysfunctionsrevertpartiallyandlateaftersuccessfuldirectactingantiviraltreatment AT giorgiopalu inchronichepatitiscinfectionmyeloidderivedsuppressorcellaccumulationandtcelldysfunctionsrevertpartiallyandlateaftersuccessfuldirectactingantiviraltreatment AT antonellacaputo inchronichepatitiscinfectionmyeloidderivedsuppressorcellaccumulationandtcelldysfunctionsrevertpartiallyandlateaftersuccessfuldirectactingantiviraltreatment |
_version_ |
1725011864032641024 |